Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

10 industry names in the news of late

No. 4: Amgen supplies HHS with drug used to fight blood cell injuries from acute radiation syndrome in radiological and nuclear emergencies (Oct. 4).

Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

‘Relatively new’ contrast vendor releases second generic agent

A global tech and pharma supplier that introduced a generic equivalent to GE Healthcare’s Visipaque during the height of the 2022 contrast shortage has begun offering a substitute for Guerbet’s Dotarem.

Female Medical Research Scientist Working with Brain Scans

FDA approves AI analysis of high-grade gliomas

An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.

Google Cloud intros ambitious branch dedicated to medical imaging

A Big Four tech company has launched a platform it hopes will accelerate data interoperability and AI adoption in, specifically, medical imaging.

Mr. O’Lear receives his sentence: 15 years and $2M

The criminal saga of the X-ray business owner who got caught fleecing CMS of $2 million—while grabbing for another $1.7 million or so—has reached its epilogue.

3 new POCUS products demoed for emergency docs

Butterfly Network, Mindray and Philips introduced new point-of-care ultrasound offerings at ACEP 2022, the annual scientific assembly of the American College of Emergency Physicians.

Thumbnail

FDA clears 2D image-reconstruction product for 3D MRI

GE Healthcare may ship its deep learning-based image reconstruction software called AIR Recon DL with new 3D capabilities, the company announced Sept. 29.

Thumbnail

New amyloid buster significantly hinders Alzheimer’s advance

An experimental Alzheimer’s drug therapy has slowed cognitive and functional decline by 27% versus placebo in a double-blind, randomized study of 1,795 individuals with early signs and symptoms of the disease.